(1R,3s,5S)-8-benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]Octane, 98%, 5g

malonic acid dibutyl ester, 95.0%, 100g

(3,4-Dihydro-1H-isoquinolin-2-yl)-acetic acid hydrochloride, 95.0%, 5g

2-Bromobenzylsulfonamide, 97.0%, 10g

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

7-CHLORO-2-IODOIMIDAZO[1,2-A]PYRIDINE, 95.0%, 250mg

1-(3-methylphenyl)-1H-pyrrole-2,5-dione, 5g

(2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-ol, 95.0%, 500mg

(R)-2-Amino-3-(5-bromo-1H-indol-3-yl)propanoic acid, 95.0%, 500mg

a-Cyclohexyl-a-phenyl-4-pyridinemethanol, 50mg

Ethyl 3-oxo-2-azabicyclo[2.2.2]octane-4-carboxylate, 98%, 100mg

4-Bromo-3-(difluoromethyl)-1-methyl-1H-pyrazole, 95.0%, 5g

4-BROMO-6-METHYL-2H-PYRAN-2-ONE, 95.0%, 5g